Larissa C. Bergin

Larissa Bergin's practice is focused on addressing the antitrust concerns for Fortune 500 companies that arise from mergers and acquisitions, joint venture formations, federal investigations, and commercial practices. She has overseen the antitrust aspects of corporate M&A, including due diligence, Hart-Scott-Rodino (HSR) filings, Second Requests, investigational hearings, integration planning, and consent decrees with federal agencies. She works with clients in a variety of industries, including the technology, health care, retail, and pharmaceutical sectors. Many of Larissa's clients have international reach, and she has been involved in matters that require advocacy before governments in Japan, China, Germany, Korea, Singapore, Taiwan, and Canada.

Larissa also advises clients on corporate contracting and operational practices that can run afoul of the antitrust laws, including supplier agreements, information sharing, competitive benchmarking, and Robinson-Patman Act pricing matters. [1]